AI Is Entering a New Era of Biological Research
Artificial intelligence is moving beyond language, images and software development and increasingly into the field of biology.
Specialised AI systems can analyse enormous amounts of genetic information, identify patterns in viral sequences and help researchers predict important biological properties. These capabilities are opening new possibilities for understanding infectious diseases.
How AI Can Analyse Viral Biology
Genomic AI models can learn patterns from large collections of biological sequences.
In much the same way that language models learn patterns in human language, biological models can identify relationships within genetic information. This can help researchers study how viruses change and how particular genetic characteristics may affect their behaviour.
Potential Benefits for Medicine
One of the most promising applications is disease prevention and treatment.
AI systems can help predict characteristics of emerging viral variants, potentially allowing researchers to prepare vaccines or treatments before a dangerous variant becomes widespread. Some AI-based approaches are also being used to study how viruses interact with the human immune system.
AI-Designed Viral Genomes
Recent research has demonstrated that specialised genomic AI models can generate entirely new viral genetic designs.
A 2025 research breakthrough involving the Evo genomic model demonstrated the generation of new bacteriophage genomes. These viruses target bacteria rather than human cells, and the research could eventually contribute to areas such as phage therapy for antibiotic-resistant bacterial infections.
The development represents an important shift from simply analysing biological sequences to using AI as a tool for biological design.
The Dual-Use Problem
The same capability that makes AI useful for medicine can also create dual-use risks.
AI-assisted biological research could help scientists develop better vaccines and treatments. But similar capabilities could potentially be misused to explore harmful biological systems.
This is why experts increasingly emphasise the need for strong biosecurity measures alongside advances in AI-enabled biology.
AI Does Not Mean Instant Creation of a Dangerous Human Virus
The ability of AI to generate or analyse viral genetic information should not be confused with the idea that an AI system can independently create a dangerous human pathogen.
Biological research involves complex experimental processes, specialised laboratory capabilities, validation and extensive safety controls.
The distinction between what an AI model can theoretically propose and what can actually be produced and safely tested in the real world is therefore important.
AI Could Transform Vaccine Development
AI's potential in vaccine research is already attracting significant scientific attention.
In 2026, researchers tested an AI-designed vaccine component in an early-stage human clinical trial. The approach uses a computer-designed antigen intended to provide broad protection against related coronavirus threats.
Such approaches could eventually help scientists prepare vaccines against virus families before new variants or related viruses emerge.
Why Biosecurity Matters
As AI becomes more capable in biology, safeguards will need to evolve alongside the technology.
Researchers, governments and technology companies may need stronger systems for access control, safety evaluation, oversight and responsible use of biological AI tools.
The challenge is to ensure that useful scientific capabilities remain available to legitimate researchers while reducing opportunities for misuse.
The Future of AI and Biology
The combination of AI and synthetic biology could significantly reshape healthcare.
Potential applications include faster vaccine development, improved antiviral discovery, better prediction of emerging pathogens and new approaches to treating antibiotic-resistant infections.
But scientific progress will need to be accompanied by equally strong attention to biosecurity, ethics and regulation.
The central question is therefore not simply whether AI can design biological systems, but how society can ensure that increasingly powerful AI-biology technologies are developed and used safely.









